Emerging therapies for non-small cell lung cancer
Recent advances in the field of novel anticancer agents prolong patients' survival and show
a promising future. Tyrosine kinase inhibitors and immunotherapy for lung cancer are the …
a promising future. Tyrosine kinase inhibitors and immunotherapy for lung cancer are the …
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy
M Zhou, X Chen, H Zhang, L Xia, X Tong… - Cancer …, 2019 - Wiley Online Library
Abstract Background On May 8, 2018, the China National Medical Products Administration
(NMPA) approved anlotinib, an orally administered anti‐angiogenesis inhibitor, for the …
(NMPA) approved anlotinib, an orally administered anti‐angiogenesis inhibitor, for the …
Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer
H Liang, M Wang - Cancer Management and Research, 2019 - Taylor & Francis
In the latest years, some drugs have been approved by European Medicines Agency (EMA)
and/or the US Food and Drug Administration (FDA) for the treatment of patients with …
and/or the US Food and Drug Administration (FDA) for the treatment of patients with …
Advanced intrahepatic cholangiocarcinoma treated using anlotinib and microwave ablation: A case report
A Zhang, B Liu, D Xu, Y Sun - Medicine, 2019 - journals.lww.com
Interventions: The patient had received 5 cycles of transhepatic arterial chemotherapy and
embolization and 1 cycle of microwave ablation. Due to rapid tumor progression and loss of …
embolization and 1 cycle of microwave ablation. Due to rapid tumor progression and loss of …
[HTML][HTML] Establishment of the prognosis predicting signature for endometrial cancer patient
J Tang, W Ma, L Luo - … medical journal of experimental and clinical …, 2019 - ncbi.nlm.nih.gov
Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
The Short-Term Efficacy and Safety of Anlotinib Combined With Chemotherapy in Treatment of Advanced Soft Tissue Sarcoma
Y Wang - Biotechnology Frontier, 2019 - ivypub.org
Soft tissue sarcoma has a strong tendency of local recurrence and metastasis, and the
treatment results after metastasis are not ideal. Alonitide, as a newly developed oral small …
treatment results after metastasis are not ideal. Alonitide, as a newly developed oral small …